Sanjay Gupta: Can Science and God Coexist?
Faith and science may often seem at odds with one another, but renowned geneticist and former NIH director, Dr. Francis Collins, says that he sees…
Thought Leader: Sanjay Gupta
(Original source PR Newswire)
“MALVERN, Pa., June 8, 2015 /PRNewswire/ — SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced two appointments: Dr. Sanjay Gupta, a renowned physician with pain management expertise, to its Scientific Advisory Board; and Dr. Philip Gerbino, an award-winning global pharmaceutical consultant, as a Strategic Advisor.
These appointments further strengthen SCILEX’s proprietary drug development program, which includes ZTlido™ (lidocaine patch 1.8%) a next-generation patch being developed for the treatment of postherpetic neuralgia, or after-shingles pain.”
Click here to read more
Sanjay Gupta: Can Science and God Coexist?
Faith and science may often seem at odds with one another, but renowned geneticist and former NIH director, Dr. Francis Collins, says that he sees…
Thought Leader: Sanjay Gupta
Marc Short on what to expect from DOGE in relation to next year’s legislative agenda
Marc Short comments on what to expect from DOGE in relation to next year’s legislative agenda for CNBC. Looking for a great keynote or public…
Thought Leader: Marc Short
Marc Short on whether Musk has permanently changed how congressional communication functions
In this video, Marc Short joins CNBC to discuss whether Musk and Twitter have permanently changed how congressional communication functions and what to expect for…
Thought Leader: Marc Short